| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | manganese ion binding | 2.38e-04 | 71 | 34 | 3 | GO:0030145 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 4.23e-04 | 18 | 34 | 2 | GO:0004016 | |
| GeneOntologyMolecularFunction | lyase activity | 4.46e-04 | 212 | 34 | 4 | GO:0016829 | |
| GeneOntologyMolecularFunction | cyclase activity | 7.59e-04 | 24 | 34 | 2 | GO:0009975 | |
| GeneOntologyMolecularFunction | magnesium ion binding | 7.92e-04 | 247 | 34 | 4 | GO:0000287 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 8.24e-04 | 25 | 34 | 2 | GO:0016849 | |
| Domain | Nucleotide_cyclase | 4.55e-04 | 18 | 33 | 2 | IPR029787 | |
| Domain | - | 4.55e-04 | 18 | 33 | 2 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_2 | 5.08e-04 | 19 | 33 | 2 | PS50125 | |
| Domain | GUANYLATE_CYCLASE_1 | 5.08e-04 | 19 | 33 | 2 | PS00452 | |
| Domain | A/G_cyclase | 5.08e-04 | 19 | 33 | 2 | IPR001054 | |
| Domain | CYCc | 5.08e-04 | 19 | 33 | 2 | SM00044 | |
| Domain | Guanylate_cyc | 5.08e-04 | 19 | 33 | 2 | PF00211 | |
| Domain | Pkinase_C | 1.94e-03 | 37 | 33 | 2 | IPR017892 | |
| Domain | Pkinase_C | 2.49e-03 | 42 | 33 | 2 | PF00433 | |
| Domain | AGC-kinase_C | 4.39e-03 | 56 | 33 | 2 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 4.39e-03 | 56 | 33 | 2 | PS51285 | |
| Domain | S_TK_X | 4.39e-03 | 56 | 33 | 2 | SM00133 | |
| Domain | Olfact_rcpt | 4.88e-03 | 393 | 33 | 4 | IPR000725 | |
| Pubmed | NDR functions as a physiological YAP1 kinase in the intestinal epithelium. | 9.28e-07 | 2 | 34 | 2 | 25601544 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 15037617 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 23897809 | ||
| Pubmed | Human NDR kinases control G(1)/S cell cycle transition by directly regulating p21 stability. | 2.78e-06 | 3 | 34 | 2 | 21262772 | |
| Pubmed | HIV-1 incorporates and proteolytically processes human NDR1 and NDR2 serine-threonine kinases. | 2.78e-06 | 3 | 34 | 2 | 15582665 | |
| Pubmed | 5.56e-06 | 4 | 34 | 2 | 19062280 | ||
| Pubmed | Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein. | 5.56e-06 | 4 | 34 | 2 | 15197186 | |
| Pubmed | Ndr kinases regulate retinal interneuron proliferation and homeostasis. | 9.26e-06 | 5 | 34 | 2 | 30135513 | |
| Pubmed | Human Mob proteins regulate the NDR1 and NDR2 serine-threonine kinases. | 9.26e-06 | 5 | 34 | 2 | 15067004 | |
| Pubmed | Loss of NDR1/2 kinases impairs endomembrane trafficking and autophagy leading to neurodegeneration. | 1.39e-05 | 6 | 34 | 2 | 36446521 | |
| Pubmed | 6.82e-05 | 730 | 34 | 6 | 34857952 | ||
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 8.38e-05 | 14 | 34 | 2 | 14993377 | |
| Pubmed | Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. | 1.41e-04 | 18 | 34 | 2 | 20064376 | |
| Pubmed | Large-scale phage-based screening reveals extensive pan-viral mimicry of host short linear motifs. | 2.53e-04 | 24 | 34 | 2 | 37100772 | |
| Pubmed | Embryonic Steroids Control Developmental Programming of Energy Balance. | 3.21e-04 | 27 | 34 | 2 | 34599818 | |
| Pubmed | 9.35e-04 | 46 | 34 | 2 | 29969578 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p32 | 2.09e-04 | 155 | 34 | 3 | chr1p32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q11 | 4.08e-04 | 40 | 34 | 2 | chr11q11 | |
| Cytoband | 11q11 | 5.64e-04 | 47 | 34 | 2 | 11q11 | |
| Cytoband | 1p32.3 | 9.48e-04 | 61 | 34 | 2 | 1p32.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 1.79e-03 | 325 | 34 | 3 | chr9q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 4.66e-03 | 137 | 34 | 2 | chr1p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 5.34e-03 | 147 | 34 | 2 | chr15q15 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 5.20e-05 | 10 | 20 | 2 | 53 | |
| GeneFamily | Olfactory receptors, family 4 | 8.82e-03 | 129 | 20 | 2 | 151 | |
| Disease | testosterone measurement | 2.61e-03 | 1275 | 33 | 6 | EFO_0004908 | |
| Disease | alkaline phosphatase measurement | 5.08e-03 | 1015 | 33 | 5 | EFO_0004533 | |
| Disease | sleep duration, triglyceride measurement | 6.05e-03 | 104 | 33 | 2 | EFO_0004530, EFO_0005271 | |
| Disease | free androgen index | 8.32e-03 | 374 | 33 | 3 | EFO_0007005 | |
| Disease | glucose measurement | 8.68e-03 | 380 | 33 | 3 | EFO_0004468 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QMPYPCFVDDSFMII | 636 | P78363 | |
| TMPTCSFPEYFIGNM | 806 | O43306 | |
| PERPFMDYFDGVLMF | 31 | Q96PN6 | |
| TFVVSPPFEYFIMAM | 1466 | Q00975 | |
| GFRPPMDYAFSDLMR | 496 | Q96SC8 | |
| MHDPFAMRPFFGYNF | 476 | P35558 | |
| PYMPYEFTCEGMLQR | 601 | Q09328 | |
| ITSFPFSPGMYFEMI | 256 | O00214 | |
| ACVIPYFRAMFLSEM | 86 | Q9P2G9 | |
| IPFFFMYMVAISGNC | 41 | Q9H341 | |
| VIFFGPCTFMYMRPD | 246 | Q8NH73 | |
| PCTFMYMRPDTTFSE | 251 | Q8NH73 | |
| FVINRPDTPYGMMNF | 791 | Q68DD2 | |
| VFYAMSPVAPRDFML | 681 | Q3MIN7 | |
| GFMLTPIAMSFPFCR | 156 | Q8NGZ9 | |
| PPFTMCFRVKFYPAD | 86 | Q7Z6J6 | |
| FFGIRPAFMCYVPSP | 51 | Q96C92 | |
| VEPMSCYMEHRFLFP | 861 | Q5TEA3 | |
| VYPFMRSVMEAPFPA | 621 | Q68D51 | |
| CVSMPPYFRFLTLMA | 171 | Q05932 | |
| YMCPFMQFIEGGRRF | 431 | P53992 | |
| VPFYDCYEPMVRMAG | 156 | Q6YP21 | |
| CYEPMVRMAGATPVF | 161 | Q6YP21 | |
| PIFFLYMMIDGVFRG | 366 | Q93100 | |
| PEYYPNCEVVFMGMA | 336 | Q13615 | |
| PCIFMYTCLATVFPM | 251 | Q8NGL9 | |
| ICMMDFVYGDPIRFL | 101 | Q9Y3C5 | |
| MFLEIMAPVYPICFT | 176 | Q96GQ5 | |
| IMYEMLIGYPPFCSE | 311 | Q15208 | |
| VIMYEMLIGYPPFCS | 311 | Q9Y2H1 | |
| DEPTFSFFSGPYMVM | 246 | Q8IWB6 | |
| PAGRKDAFYPPFCMF | 456 | Q2VWA4 | |
| EKIFMPFRMSGYIPF | 101 | Q8TD22 | |
| GIPSYCFALMVMFFL | 516 | Q5TAX3 | |
| MRFTCEMFHPNIYPD | 71 | P60604 | |
| LCPLPFSMEEMFGFI | 656 | Q9P2D8 |